LivaNova (LIVN) Cash & Equivalents (2014 - 2026)
LivaNova (LIVN) posted Cash & Equivalents of $539.7 million for Q1 2026, down 15.08% sequentially from $635.6 million in Q4 2025, and down 26.91% YoY from $738.4 million in Q1 2025.
LivaNova (LIVN) Cash & Equivalents (2014 - 2026) Analysis & Trends
LivaNova has reported Cash & Equivalents for 13 years, with the latest figure at $539.7 million in Q1 2026.
- Quarterly Cash & Equivalents fell 26.91% year-over-year to $539.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $539.7 million (down 26.91% YoY) and the FY2025 annual result came in at $635.6 million, up 48.2% from the prior year.
- Cash & Equivalents declined to $539.7 million in Q1 2026 per LIVN's latest filing, from $635.6 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $738.4 million in Q1 2025 and troughed at $275.2 million in Q3 2022.
- A 5-year average of $381.2 million and a median of $311.4 million in 2023 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2025 and 2026: Cash & Equivalents jumped 140.93% in 2025, then declined 26.91% in 2026.
- Over 5 years, Cash & Equivalents stood at $301.4 million in 2022, then climbed by 3.29% to $311.4 million in 2023, then jumped by 37.73% to $428.9 million in 2024, then surged by 48.2% to $635.6 million in 2025, then retreated by 15.08% to $539.7 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $539.7 million, $635.6 million, and $738.4 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 482.30 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 516.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 516.62 Mn |
| Mar 31, 2026 | 539.71 Mn |
| Dec 31, 2025 | 635.55 Mn |
| Mar 31, 2025 | 738.44 Mn |
| Dec 31, 2024 | 428.86 Mn |
| Sep 30, 2024 | 346.37 Mn |
| Jun 30, 2024 | 303.88 Mn |
| Mar 31, 2024 | 306.50 Mn |
| Dec 31, 2023 | 311.37 Mn |
| Sep 30, 2023 | 298.80 Mn |
| Jun 30, 2023 | 311.43 Mn |
| Mar 31, 2023 | 308.60 Mn |
| Dec 31, 2022 | 301.45 Mn |
| Sep 30, 2022 | 275.20 Mn |
| Jun 30, 2022 | 297.75 Mn |
| Mar 31, 2022 | 313.60 Mn |
| Sep 30, 2021 | 181.85 Mn |
| Jun 30, 2021 | 329.39 Mn |
| Mar 31, 2021 | 252.54 Mn |
| Dec 31, 2020 | 252.83 Mn |